{"id":246,"date":"2026-06-01T01:10:29","date_gmt":"2026-06-01T01:10:29","guid":{"rendered":"https:\/\/thesynchromystic.com\/?p=246"},"modified":"2026-06-01T01:10:29","modified_gmt":"2026-06-01T01:10:29","slug":"the-liability-laundering-machine","status":"publish","type":"post","link":"https:\/\/thesynchromystic.com\/index.php\/2026\/06\/01\/the-liability-laundering-machine\/","title":{"rendered":"The Liability Laundering Machine"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"577\" src=\"https:\/\/thesynchromystic.com\/wp-content\/uploads\/2026\/06\/Featured-Image-_-Website-composite_17802761565177-1024x577.jpg\" alt=\"\" class=\"wp-image-248\" srcset=\"https:\/\/thesynchromystic.com\/wp-content\/uploads\/2026\/06\/Featured-Image-_-Website-composite_17802761565177-1024x577.jpg 1024w, https:\/\/thesynchromystic.com\/wp-content\/uploads\/2026\/06\/Featured-Image-_-Website-composite_17802761565177-300x169.jpg 300w, https:\/\/thesynchromystic.com\/wp-content\/uploads\/2026\/06\/Featured-Image-_-Website-composite_17802761565177-768x432.jpg 768w, https:\/\/thesynchromystic.com\/wp-content\/uploads\/2026\/06\/Featured-Image-_-Website-composite_17802761565177-1536x865.jpg 1536w, https:\/\/thesynchromystic.com\/wp-content\/uploads\/2026\/06\/Featured-Image-_-Website-composite_17802761565177.jpg 1600w\" sizes=\"auto, (max-width: 767px) 89vw, (max-width: 1000px) 54vw, (max-width: 1071px) 543px, 580px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Who really bears the costs and risks of modern medicine?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this new essay, I argue that the pharmaceutical industry&#8217;s greatest innovation may not be biomedical at all. Rather, it may be <em>institutional<\/em>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Drawing upon legal history, public-choice economics, critical theory, and political economy, I trace how research costs, testing risks, malpractice exposure, and legal liability are systematically redistributed away from manufacturers and onto taxpayers, physicians, and patients.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Topics include the Bayh-Dole Act, off-label prescribing, the learned intermediary doctrine, regulatory capture, direct-to-consumer advertising, and the broader logic of instrumental rationality.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Whether one ultimately agrees or disagrees with the thesis, the resulting picture raises profound questions about how modern institutions distribute risk, responsibility, and reward.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read the full essay on <a href=\"https:\/\/matthewjbell.substack.com\/p\/the-liability-laundering-machine\">Substack<\/a>. (Companion video is forthcoming.)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Who really bears the costs and risks of modern medicine? In this new essay, I argue that the pharmaceutical industry&#8217;s greatest innovation may not be biomedical at all. Rather, it may be institutional. Drawing upon legal history, public-choice economics, critical theory, and political economy, I trace how research costs, testing risks, malpractice exposure, and legal &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thesynchromystic.com\/index.php\/2026\/06\/01\/the-liability-laundering-machine\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;The Liability Laundering Machine&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[1],"tags":[449,458,447,453,454,451,444,450,456,448,457,452,439,455,442,441,443,440,446,445,437,459],"class_list":["post-246","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-bayh-dole","tag-corporate-power","tag-critical-theory","tag-economics","tag-fda","tag-frankfurt-school","tag-healthcare","tag-institutional-analysis","tag-legal-theory","tag-max-weber","tag-medicine","tag-milton-friedman","tag-neoliberalism","tag-nih","tag-pharmaceuticals","tag-political-economy","tag-public-choice-theory","tag-public-health","tag-public-policy","tag-regulatory-capture","tag-synchromystique","tag-thesynchromystic"],"_links":{"self":[{"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/posts\/246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/comments?post=246"}],"version-history":[{"count":1,"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/posts\/246\/revisions"}],"predecessor-version":[{"id":249,"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/posts\/246\/revisions\/249"}],"wp:attachment":[{"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/media?parent=246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/categories?post=246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thesynchromystic.com\/index.php\/wp-json\/wp\/v2\/tags?post=246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}